Ori News, Insights & Publications.

Articles | Insights |

Modular Bioprocess Platforms for Gene-Edited Therapies

To make enough gene-edited therapies for more patients and to …

Insights |

Endpoints Cell and Gene Day 2025: The Path to Commercial Viability for Cell and Gene Therapies

At Endpoints Cell and Gene Day 2025, a panel of …

Articles | Insights |

AI, ML, and digitalization systems in the cell and gene therapy sector: a guidance document from the ISCT industry committees

Keara Trinkle (Traylor), Director, Technical Solutions at Ori Biotech, co-authored …

Insights |

Ori Whitepaper: Best-of-Breed

How Combining Best-of-Breed Technology and Services Can Ensure Commercial Success …

Articles |

Improving CGT Production to Speed Delivery and Lower Cost

Improving CGT Production to Speed Delivery and Lower Cost …

Insights |

Molecule to Market: The master-builder now on a cell therapy crusade

In this episode of Molecule to Market, you’ll go inside …

News |

Ori Biotech looks to overcome cell and gene therapy manufacturing challenges

By automating and digitizing critical processes, Ori’s platform is designed …

Insights |

The Impact of Automation on Costs and Variability (Part 3)

In the final part of his video interview with Pharma …

Insights |

Overcoming Bottlenecks in Personalized Medicine Manufacturing (Part 2)

In the second part of his video interview Jason C. …

Insights |

Unlocking the Potential of Cell and Gene Therapies (Part 1)

In the first of three video interviews Jason C. Foster, …

Insights |

Tackling Critical CGT Bottlenecks and Envisioning the Future (Part 2)

Jason C. Foster, CEO and executive director of Ori Biotech, …

Insights |

Reflections on Achieving Commercial-Scale CGT Manufacturing Capability (Part 1)

Jason C. Foster, CEO and executive director of Ori Biotech, …